Importance of ultrasound measurement of the liver and spleen size in the diagnosis of comorbidity with malaria and COVID-19
Abstract
Background/Aim. With the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, patients who had malaria and COVID-19 simultaneously were also noticed. Hepatosplenomegaly is characteristic and almost always present in patients with malaria (without associated COVID-19). A significant increase in the size of the liver and spleen clearly indicates the possible development of severe malaria. The aim of this study was to determine the effect of COVID-19 on liver and spleen size in patients with malaria. Methods. This study was conducted while the authors were working in the Serbian Military Hospital of the United Nations Multidimensional Integrated Stabilization Mission (MINUSCA-UN) in Bangui, Central African Republic. Data from 1,710 patients who underwent ultrasound examination of the abdomen, where the diameters of the liver and spleen were monitored, were analyzed. The total number of examined patients was divided into four groups: group with 816 control patients without malaria (C group), 480 with active malaria (M+), 353 patients who had malaria in the past 2–6 months (Mpast), and 61 patients with active malaria and active COVID-19 (M+Cov+). Results. The liver size was significantly greater in the M+, Mpast, and M+Cov+ groups of respondents compared with the C group. Statistically significant spleen enlargement was observed only in the M+ group but not in the M+Cov+ group compared to the C group. Conclusion. There is no enlargement of the spleen in patients with a coinfection with the severe acute respiratory syndrome coronavirus 2 and Plasmodium malariae. Therefore, in the presence of clear splenomegaly, we can indicate, with a high probability, the absence of COVID-19 while waiting for the results of the polymerase chain reaction test, even in the first hours of hospitalization.
References
World Health Organization. WHO guidelines for malaria, 16 February 2021 [Internet]. Geneva: WHO; 2021 [cited 2023 Apr 11; accessed 2024 Dec 4]. Available from: https://
iris.who.int/handle/10665/339609
World Health Organization. Severe Malaria. Trop Med Int Health 2014; 19 (Suppl 1): 7–131.
African Leaders Malaria Alliance. Central African Republic ALMA Quarterly Report, Quarter One, 2021 [Internet]. 2021 [accessed 2024 Dec 17]. Available from: https://alma2030.org/
wp-content/uploads/2023/01/central-african-republic-qua
rterly-report-2021-q1-en.pdf
World Health Organization. World malaria report 2020 [Inter-net]. Geneva: WHO; 2020 [cited 2023 Apr 10; accessed 2024 Dec 4]. Available from: https://www.who.int/publications/i/
item/9789240015791
World Health Organization. World malaria report 2015 [Inter-net]. Geneva: WHO; 2015. p. 238 [accessed 2024 Dec 4]. Available from:https://iris.who.int/bitstream/handle/10665/200018/9789241565158_eng.pdf
World Health Organization. World malaria report 2021 [Inter-net]. Geneva: WHO; 2021. p. 322 [accessed 2024 Dec 4]. Available from: https://www.who.int/publications/i/item/9789240040
World Health Organization. WHO Guidelines for malaria [Inter-net]. Geneva: WHO; 2021. pp. 61–73 [accessed 2024 Dec 4]. Available from: https://extranet.who.int/prequal/sites/defa
ult/files/document_files/WHO_Guidelines_Malaria_February2021.pdf
Matlani M, Kojom LP, Mishra N, Dogra V, Singh V. Severe vi-vax malaria trends in the last two years: a study from a tertiary care centre, Delhi, India. Ann Clin Microbiol Antimicrob 2020; 19(1): 49.
Bennett WN. Malaria Clinical Presentation [Internet]. Newark: Medscape; 2020 [accessed 2024 Dec 4]. Available from: https://emedicine.medscape.com/article/221134-clinical#b3
Kusotera T, Nhengu TG. Coronavirus-19 and malaria: The great mimics. Afr J Prim Health Care Fam Med 2020; 12(1): e1–3.
Harris RE, Rosemurgy AS. COVID-19 and Malaria: A Fatal Attraction for SARS CoV-2? J Epidemiol Public Health Rev 2020; 5(2): 1–3.
Di Gennaro F, Marotta C, Locantore P, Pizzol D, Putoto G. Malar-ia and COVID-19: Common and Diferent Findings. Trop Med Infect Dis 2020; 5(3): 141.
Chanda-Kapata P, Kapata N, Zumla A. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries. Int J Infect Dis 2020; 94: 151–3.
Hussein MIH, Albashir AAD, Elawad OAMA, Homeida A. Ma-laria and COVID‑19: unmasking their ties. Malar J 2020; 19(1): 457.
Sebastião CS, Gaston C, Paixão JP, Sacomboio ENM, Neto Z, de Vasconcelos JN, et al. Coinfection between SARS-CoV-2 and vector-borne diseases in Luanda, Angola. J Med Virol 2022; 94(1): 366–71.
Riestra-Candelaria BL, Rodriguez-Mojica W, Jorge HC. Anatomi-cal criteria to measure the adult right liver lobe by ultrasound. Sonography 2018; 5(4): 181–6.
Gameraddin MB, Ali AM, Al-Raddadi M, Haleeb M, Alshoabi SA. The Sonographic Dimensions of the Liver at Normal Sub-jects Compared to Patients with Malaria. Int J Med Imaging 2015; 3(36): 130–6.
Özmen Z, Aktaş F, Özmen ZC, Almus E, Demir O. Ultrasound measurement of liver longitudinal length in a North Anatolian Population: A community‑based study. Niger J Clin Pract 2018; 21(5): 653–7.
Niederau C, Sonnenberg A, Müller JE, Erckenbrecht JF, Scholten T, Fritsch WP. Sonographic measurements of the normal liver, spleen, pancreas, and portal vein. Radiology 1983; 149(2): 537–40.
Benter T, Klühs L, Teichgräber U. Sonography of the spleen. J Ultrasound Med 2011; 30(9): 1281–93.
Badran DH, Kalbouneh HM, Al-Hadidi MT, Shatarat AT, Ta-rawneh ES, Hadidy AM, et al. Ultrasonographic assessment of splenic volume and its correlation with body parameters in a Jordanian population. Saudi Med J 2015; 36(8): 967–72.
Sherrard-Smith E, Hogan AB, Hamlet A, Watson OJ, Whittaker C, Winskill P, et al. The potential public health consequences of COVID-19 on malaria in Africa. Nat Med 2020; 26(9): 1411–6.
Diongue K, Diallo MA. COVID-19 during malaria transmission season in Africa and why we should be prepared: An example from Senegal. Afr J Lab Med 2020; 9(1): 1332.
Directorate General of Health Services. Guidelines for manage-ment of co-infection of COVID-19 with other seasonal epi-demic prone diseases [Internet]. [cited 2024 Sep 11; accessed 2024 Dec 4]. Available from: https://covid19dashboard.mohfw.
gov.in/pdf/GuidelinesformanagementofcoinfectionofCOVID19withotherseasonalepidemicpronediseases.pdf
Teboh-Ewungkem MI, Ngwa GA. COVID-19 in malaria-endemic regions: potential consequences for malaria interven-tion coverage, morbidity, and mortality. Lancet Infect Dis 2021; 21(1): 5–6.
Junaedi M, Katu S, Ilyas M, Daud M, Saleh S, Rasyid H, et al. Case Report: Covid-19 and severe malaria co-infection. Eur J Mol Clin Med 2020; 7(8): 961–8.
Rahi M, Das P, Sharma A. COVID-19 Mitigation Steps Pro-vide a Blueprint for Malaria Control and Elimination. Am J Trop Med Hyg 2020; 103(1); 28–30.
Acquah S. Implications of COVID-19 Pandemic on Evolution of Diabetes in Malaria-Endemic African Region. J Diabetes Res 2020; 2020: 8205261.
Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, et al. Potential impact of the COVID-19 pan-demic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health 2020; 8(9): e1132–41. Erratum in: Lancet Glob Health 2021; 9(1): e23.
Shahid Z, Karim N, Shahid F, Yousaf Z. COVID-19 Associated Imported Plasmodium vivax Malaria Relapse: First Reported Case and Literature Review. Res Rep Trop Med 2021; 12: 77–80.
World Health Organization. World malaria report 2020: 20 years of global progress and challenges. Geneva: WHO; 2020 [ac-cessed 2024 Dec 4]. Available from: https://iris.who.int
/handle/10665/337660
Olivier BMB, Eliezer MP, Ngatimo EV, Pierrette BKE, Tsalefac M, Chrysostome GJ. Influence of climate variability on the dy-namics of malaria transmission among children in Bangui, health challenges in Central African Republic. Open J Pediatr 2022; 12(3): 461–75.